Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Penas

Showing results (51-60 of 105) with videos related to

Pageof 11
Sort By:
Journal of Neuro-Oncology|November 19, 2023
Capturing evolving definitions of 12 select rare CNS tumors: a timely report from CBTRUS and NCI-CONNECTMackenzie Price, Corey Neff, Carol Kruchko, et al.
European Journal of Cancer (Oxford, England : 1990)|April 6, 2019
Clinical trial participation of patients with glioblastoma at The University of Texas MD Anderson Cancer CenterRebecca A Harrison, Mark D Anderson, David Cachia, et al.
Neuro-Oncology|May 6, 2024
CBTRUS Statistical Report: American Brain Tumor Association & NCI Neuro-Oncology Branch Adolescent and Young Adult Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016-2020Mackenzie Price, Corey Neff, Nitin Nagarajan, et al.
Cancers|January 21, 2022
The Alliance AMBUSH Trial: Rationale and DesignAnita Mahajan, Helen Shih, Marta Penas-Prado, et al.
Neuro-Oncology Practice|July 15, 2026
Natural history study of adults with primary central nervous system tumors: Initial results for first 1000 participantsKimberly R Robins, Hope Miller, Michelle L Cassidy, et al.
Neuro-Oncology Advances|March 5, 2025
ICAM-1 and IL-10 are associated with cognitive dysfunction using the MoCA test in glioma: Findings from the NCI Neuro-Oncology Branch Natural History StudyKaitlynn Slattery, McKenzie C Kauss, Dhaivat Raval, et al.
Neuro-Oncology Practice|June 9, 2025
Implications of sociodemographic and clinical factors on symptom burden: Age-specific survivorship care in the primary central nervous system tumor populationKimberly R Robins, Tricia Kunst, Jennifer Reyes, et al.
Neuro-Oncology Advances|July 10, 2020
NCI-CONNECT: Comprehensive Oncology Network Evaluating Rare CNS Tumors-Histone Mutated Midline Glioma Workshop ProceedingsBrett J Theeler, Yamini Dalal, Michelle Monje, et al.
Journal of Neuro-Oncology|July 14, 2016
A randomized phase II trial of standard dose bevacizumab versus low dose bevacizumab plus lomustine (CCNU) in adults with recurrent glioblastomaShiao-Pei Weathers, Xiaosi Han, Diane D Liu, et al.
Frontiers in Oncology|March 20, 2026
Case Report: Molecular diagnostics and clinical courses of two adult spinal pilocytic astrocytoma long-term survivors with GTF2I::BRAF fusionLorenzo Argao, Pinar E Zerk, Hsiang-Chih Lu, et al.
Pageof 11

Showing results (51-60 of 105) with videos related to

Sort By:
Pageof 11
Journal of Neuro-Oncology|November 19, 2023
Capturing evolving definitions of 12 select rare CNS tumors: a timely report from CBTRUS and NCI-CONNECTMackenzie Price, Corey Neff, Carol Kruchko, et al.
European Journal of Cancer (Oxford, England : 1990)|April 6, 2019
Clinical trial participation of patients with glioblastoma at The University of Texas MD Anderson Cancer CenterRebecca A Harrison, Mark D Anderson, David Cachia, et al.
Neuro-Oncology|May 6, 2024
CBTRUS Statistical Report: American Brain Tumor Association & NCI Neuro-Oncology Branch Adolescent and Young Adult Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016-2020Mackenzie Price, Corey Neff, Nitin Nagarajan, et al.
Cancers|January 21, 2022
The Alliance AMBUSH Trial: Rationale and DesignAnita Mahajan, Helen Shih, Marta Penas-Prado, et al.
Neuro-Oncology Practice|July 15, 2026
Natural history study of adults with primary central nervous system tumors: Initial results for first 1000 participantsKimberly R Robins, Hope Miller, Michelle L Cassidy, et al.
Neuro-Oncology Advances|March 5, 2025
ICAM-1 and IL-10 are associated with cognitive dysfunction using the MoCA test in glioma: Findings from the NCI Neuro-Oncology Branch Natural History StudyKaitlynn Slattery, McKenzie C Kauss, Dhaivat Raval, et al.
Neuro-Oncology Practice|June 9, 2025
Implications of sociodemographic and clinical factors on symptom burden: Age-specific survivorship care in the primary central nervous system tumor populationKimberly R Robins, Tricia Kunst, Jennifer Reyes, et al.
Neuro-Oncology Advances|July 10, 2020
NCI-CONNECT: Comprehensive Oncology Network Evaluating Rare CNS Tumors-Histone Mutated Midline Glioma Workshop ProceedingsBrett J Theeler, Yamini Dalal, Michelle Monje, et al.
Journal of Neuro-Oncology|July 14, 2016
A randomized phase II trial of standard dose bevacizumab versus low dose bevacizumab plus lomustine (CCNU) in adults with recurrent glioblastomaShiao-Pei Weathers, Xiaosi Han, Diane D Liu, et al.
Frontiers in Oncology|March 20, 2026
Case Report: Molecular diagnostics and clinical courses of two adult spinal pilocytic astrocytoma long-term survivors with GTF2I::BRAF fusionLorenzo Argao, Pinar E Zerk, Hsiang-Chih Lu, et al.
Pageof 11